BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Source link

You May Also Like

Building on Barcelona’s success, Spain is playing its first Women’s World Cup final against England

BARCELONA, Spain — If those precise passes that untangle defenses and the…

Twitter Limits Content Moderation Tools Ahead of Midterm Elections

Twitter Inc., the social network being overhauled by new owner Elon Musk,…

Raheem Sterling leaves World Cup due to armed burglary at London home

AL KHOR, Qatar – England star Raheem Sterling flew home from the…

Biden tells PBS he’s ‘not at liberty’ to discuss classified documents scandal, suggests his staff is to blame

President Biden offered few details about his classified document scandal in his…